Article Versions Notes

Cabello-Olmo M, Oneca M, Urtasun R, Pajares MJ, Goñi S, Riezu-Boj JI, Milagro FI, Ayo J, Encio IJ, Barajas M, et al. Pediococcus acidilactici pA1c^® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota. Pharmaceutics. 2023; 15(4):1203. https://doi.org/10.3390/pharmaceutics15041203

Cabello-Olmo, Miriam, María Oneca, Raquel Urtasun, María J. Pajares, Saioa Goñi, José I. Riezu-Boj, Fermín I. Milagro, Josune Ayo, Ignacio J. Encio, Miguel Barajas, and et al. 2023. "Pediococcus acidilactici pA1c^® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota" Pharmaceutics 15, no. 4: 1203. https://doi.org/10.3390/pharmaceutics15041203

Cabello-Olmo, M., Oneca, M., Urtasun, R., Pajares, M. J., Goñi, S., Riezu-Boj, J. I., Milagro, F. I., Ayo, J., Encio, I. J., Barajas, M., & Araña, M. (2023). Pediococcus acidilactici pA1c^® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota. Pharmaceutics, 15(4), 1203. https://doi.org/10.3390/pharmaceutics15041203